New ultrasound and DNA test could revolutionize leprosy diagnosis
NCT ID NCT07515989
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a new approach—using ultrasound to guide a tiny needle to collect fluid near the ulnar nerve, then analyzing it for leprosy bacteria DNA—can more accurately diagnose leprosy and confirm when it's cured. Researchers will follow 108 participants for one year, comparing this method to standard tests. If it works, it could lead to earlier treatment and fewer long-term disabilities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ultrasound-guided perineural subcutaneous aspirate with PCR analysis
What this could lead to
If successful, this could provide a more accurate way to diagnose leprosy early and confirm when the disease is cured, potentially reducing nerve damage and disability.
What could go wrong
This is a small, early-stage study (108 participants) testing a new diagnostic method. The technique may not prove more accurate than existing tests, and results may not apply to all leprosy patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPROSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Brasília
RECRUITINGBrasília, Federal District, 70.830-200, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••